Mupirocin Ointment Market

Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Mupirocin Ointment Market contains market size and forecasts of Mupirocin Ointment in global, including the following market information:

• Global Mupirocin Ointment Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Mupirocin Ointment Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Mupirocin Ointment companies in 2021 (%)

The global Mupirocin Ointment market was valued at 326 million in 2021 and is projected to reach US$ 377.2 million by 2028, at a CAGR of 2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Below 10g Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mupirocin Ointment include Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, Taro Pharmaceutical, Teva, Perrigo and Hanzhou Zhuyangxin Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mupirocin Ointment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mupirocin Ointment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mupirocin Ointment Market Segment Percentages, by Type, 2021 (%)

• Below 10g
• 10g-20g
• Above 20g

Global Mupirocin Ointment Market, by Sales Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mupirocin Ointment Market Segment Percentages, by Sales Channel, 2021 (%)

• Hospital
• Retail Pharmacy
• Others

Global Mupirocin Ointment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mupirocin Ointment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Mupirocin Ointment revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Mupirocin Ointment revenues share in global market, 2021 (%)
• Key companies Mupirocin Ointment sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Mupirocin Ointment sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Glenmark Pharms
• Glaxosmithkline
• SmithKline & French
• Humanwell Healthcare
• Taro Pharmaceutical
• Teva
• Perrigo
• Hanzhou Zhuyangxin Pharmaceutical

To know more about market statistics, Download a FREE Sample copy